84801-07-0

Basic information

• Product Name: 2-ALLYL BENZYLALCOHOL
• Synonyms: 2-ALLYL BENZYLALCOHOL
• CAS NO: 84801-07-0
• Molecular Formula: C₁₀H₁₂O
• Molecular Weight: 148.2
• Mol File: 84801-07-0.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 243.5°C at 760 mmHg
• Flash Point: 106.6°C
• Appearance: /
• Density: 1.003g/cm³
• Vapor Pressure: 0.0171mmHg at 25°C
• Refractive Index: 1.543
• CAS DataBase Reference: 2-ALLYL BENZYLALCOHOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ALLYL BENZYLALCOHOL(84801-07-0)
• EPA Substance Registry System: 2-ALLYL BENZYLALCOHOL(84801-07-0)

Safety Data

• Hazardous Substances Data: 84801-07-0(Hazardous Substances Data)

Usage

Properties

1. Organic compound
2. Falls under the category of benzenoids
3. Colorless liquid
4. Strong, pleasant odor
5. Commonly used as a fragrance ingredient
6. Used as a solvent in various industries
7. Has antimicrobial properties
8. Relatively safe for use in low concentrations
9. Can cause skin and eye irritation in high concentrations

Specific content

1. Name: 2-ALLYL BENZYLALCOHOL
2. Also known as: 2-propanol
3. Molecular formula: C10H12O
4. Molecular weight: 148.20 g/mol
5. Uses: fragrance ingredient, solvent, antimicrobial agent
6. Applications: perfumes, personal care products, pharmaceuticals, cosmetics, antiseptic, disinfectant products
7. Safety: relatively safe in low concentrations, can cause skin and eye irritation in high concentrations

InChI:InChI=1/C10H12O/c1-2-5-9-6-3-4-7-10(9)8-11/h2-4,6-7,11H,1,5,8H2

Upstream product

• 107-05-1 3-chloroprop-1-ene 
• 100-51-6 benzyl alcohol 
• 61463-59-0 2-allyl benzoic acid methyl ester 
• 610-97-9 o-iodo-methyl-benzoic acid 
• 62708-42-3 o-allylbenzaldehyde 
• 109946-59-0 o-(2-tetrahydropyranyloxymethyl)phenylmagnesium bromide 
• 133341-93-2 4,4-dimethyl-2-[2-(prop-2-enyl)]phenyl-2-oxazoline 
• 61436-73-5 2-allylbenzoic acid 
• 19312-06-2 4,5-dihydro-4,4-dimethyl-2-phenoxazole 
• 18982-54-2 o-bromobenzyl alcohol 
• 17100-66-2 2-(tetrahydropyranyloxy)methylbromobenzene 
• 560134-52-3 S-(4-cyano)phenyl 2-(prop-2-enyl)benzenecarbothioate 
• 159757-66-1 o-Allylbenzyl acetate 
• 106-95-6 allyl bromide 

Downstream Products

• 62708-42-3 o-allylbenzaldehyde 
• 89121-39-1 1-allyl-2-(chloromethyl)benzene 
• 81097-20-3 N-(2-allyl-benzyl)-4-methyl-benzenesulfonamide 
• 2177-47-1 2-Methylindene 
• 824-63-5 2-methylindane 
• 59059-44-8 o-propylbenzaldehyde 
• 1616-50-8 3-methyl-1-phenyl-isoquinoline 
• 1073174-99-8 (2-allylphenyl)(phenyl)methanol 

Relevant articles and documents

Copper-catalyzed enantioselective alkene carboetherification for the synthesis of saturated six-membered cyclic ethers

The enantioselective copper-catalyzed oxidative coupling of alkenols with styrenes for the construction of dihydropyrans, isochromans, pyrans and morpholines is reported. A concise formal synthesis of a σ1receptor ligand using this alkene carbo

Synthesis of Tetrahydroisoquinolines through an Iron-Catalyzed Cascade: Tandem Alcohol Substitution and Hydroamination

Rapid assembly of saturated nitrogen heterocycles - the synthetically more challenging variants of their aromatic relatives - can expedite the synthesis of biologically relevant molecules. Starting from a benzylic alcohol tethered to an unactivated alkene, an iron-catalyzed tandem alcohol substitution and hydroamination provides access to tetrahydroisoquinolines in a single synthetic step. Using a mild iron-based catalyst, the combination of these operations forms two carbon-nitrogen bonds and provides a unique annulation strategy to access this valuable core.

Macrocyclic Modulators of the Ghrelin Receptor

The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, gastrointestinal disorders, cardiovascular disorders, obesity and obesity-associated disorders, central nervous system disorders, genetic disorders, hyperproliferative disorders and inflammatory disorders.